Skip to main content
Important notice

COVID-19: Information in effect as of January 8, 2021

Our services are available online and by telephone. In compliance with the new sanitary measures and to limit physical contact, our offices are no longer accessible. If you have any questions, please refer to the webpage Questions and answers about our services during the pandemic.

Important information

The contents of this webpage are in French only.

Décision relative à la demande d’accès 7212 2018 10931

Document administratif
Updated on

 10 May 2020

La demande d’accès concerne les statistiques reliées au nombre de prescriptions pour les médicaments suivants : Adderall xr, Biphentin, Concerta, Dexedrine, Intuniv xr, Ritalin, Ritalin sr, Strattera, Vyvanse.